Skip to main content
Yifan Yu on Muck Rack

Yifan Yu

Verified
San Francisco
As seen in: Nikkei Asia, Medium, MSN UK, Color Research & Application, Financial Times, Forbes, Nature, Wiley Online Library, Yahoo Finance, MDPI, Milenio and
Tech reporter @NikkeiAsia Tips to yifan.yu@nex.nikkei.com. I no longer post on X (or whatever you call this), let's connect on LinkedIn👇

Get in touch with Yifan

Contact Yifan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Yifan Yu’s Biography

Read Full Bio →

Award-winning bilingual journalist with global working experience in the United States, Mainland China, Hong Kong, and India. Currently cover scoop-driven tech news with a special focus on Asia and US tech. Previous coverages include leveraged finance, real estate, China tech and corporate regulation.

Articles

Hierarchical Assembly of Multilayer Core–Shell DNA Origami Crystals

|
By Yifan Yu Verified, Hang Xu, Xuehui Yan
| Wiley Online Library Verified
Yifan Yu, Hang Xu, and Xuehui Yan contributed equally to this work. Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data that support the findings of this study are available in the supplementary material of this article. Supporting Information Filename Description adma74163-sup-0001-SuppMat.pdf1.9 MB Supporting File 1: adma74163-sup-0001-SuppMat.pdf. adma74163-sup-0002-MovieS1.avi9.2 MB Supporting File 2: adma74163-sup-0002-MovieS1.avi.
Open in Who Shared Issue with article?

Qualcomm vs Nvidia and drones vs dogs

|
By Yifan Yu Verified, Eleanor Olcott Verified, Shaun Turton, Haruki Kitagawa Verified
| Financial Times Verified
Hello from Yifan, your #techAsia host this week.
Open in Who Shared View Duplicates (2) Issue with article?

Predicting early-stage breast cancer disease-free survival and adjuvant therapy benefit from multimodal information using deep learning

|
By Yifan Yu Verified, Zeyan Xu, Xu Feng Huang, Kexin Chen, Zaiyi Liu, Ying Wang, Changhong Liang, Lei Wu, Zejun Zhu, Jiayi Liao
| Nature Verified
Abstract Accurate prediction of disease-free survival (DFS) is essential for tailoring adjuvant regimens and improving clinical outcomes in early-stage breast cancer (EBC).
Open in Who Shared Issue with article?
See all 203 licensed articles (703 Total)